Who makes PfSPZ-GA1 Vaccine?

PfSPZ-GA1 Vaccine is developed by Sanaria Inc..

What development phase is PfSPZ-GA1 Vaccine in?

PfSPZ-GA1 Vaccine is in Phase 1.

Last reviewed 2026-04-19 · How we verify

PfSPZ-GA1 Vaccine

Sanaria Inc. · Phase 1 active Biologic

At a glance

Generic name	PfSPZ-GA1 Vaccine
Sponsor	Sanaria Inc.
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety and Protective Efficacy of Genetically Attenuated PfSPZ-GA1 Vaccine in Healthy Dutch Volunteers (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PfSPZ-GA1 Vaccine CI brief — competitive landscape report
PfSPZ-GA1 Vaccine updates RSS · CI watch RSS
Sanaria Inc. portfolio CI